GLP-1 & PCOS: Why So Many Women Were Misdiagnosed
Linktree for Community Resources
Need help appealing GLP-1 insurance denials?
findhonestcare.com/kim
Ro - Telehealth for GLP1 Weight Management
Ro.Co/PlusSideZ
_________________________________________________________________________
What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility?
In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact.
Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention.
We discuss:
Why so many women with PCOS were misunderstood or dismissed
The connection between PCOS, PMOS, insulin resistance, obesity, and fertility
- Why weight gain is not just about willpower
- Adolescent PCOS and why early intervention matters
- GLP-1 medications like semaglutide for PCOS/PMOS
- Emerging research focused on ovulation, fertility, and metabolic health
- How hormones, appetite, and metabolism are connected
- Why the PMOS name change could improve diagnosis and treatment
Dr. Cree also shares information about her ongoing research and studies exploring how GLP-1 medications may help improve metabolic and reproductive health in people with PCOS/PMOS.
Learn more about studies
https://medschool.cuanschutz.edu/pediatrics/sections/endocrinology/endocrinology-research/cree-lab/Cree-Melanie-UCD4665?utm_source=chatgpt.com
_________________________________________________________________________
Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join
_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
Kim Carlos, Executive Producer
Kat Carter, Producer
Fler avsnitt av The Plus SideZ: A GLP-1 Guide to Metabolic Health
Visa alla avsnitt av The Plus SideZ: A GLP-1 Guide to Metabolic HealthThe Plus SideZ: A GLP-1 Guide to Metabolic Health med Kim Carlos finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.